{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362544420108522112.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1056/nejmoa1111961"}},{"identifier":{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1111961"}}],"dc:title":[{"@value":"ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382544420108522242","@type":"Researcher","foaf:name":[{"@value":"Ralph M. Meyer"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522240","@type":"Researcher","foaf:name":[{"@value":"Mary K. Gospodarowicz"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522249","@type":"Researcher","foaf:name":[{"@value":"Joseph M. Connors"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522115","@type":"Researcher","foaf:name":[{"@value":"Robert G. Pearcey"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522243","@type":"Researcher","foaf:name":[{"@value":"Woodrow A. Wells"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522114","@type":"Researcher","foaf:name":[{"@value":"Jane N. Winter"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522241","@type":"Researcher","foaf:name":[{"@value":"Sandra J. Horning"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522112","@type":"Researcher","foaf:name":[{"@value":"A. Rashid Dar"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522244","@type":"Researcher","foaf:name":[{"@value":"Chaim Shustik"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522113","@type":"Researcher","foaf:name":[{"@value":"Douglas A. Stewart"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522246","@type":"Researcher","foaf:name":[{"@value":"Michael Crump"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522248","@type":"Researcher","foaf:name":[{"@value":"Marina S. Djurfeldt"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522245","@type":"Researcher","foaf:name":[{"@value":"Bingshu E. Chen"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420108522247","@type":"Researcher","foaf:name":[{"@value":"Lois E. Shepherd"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00284793"},{"@type":"EISSN","@value":"15334406"}],"prism:publicationName":[{"@value":"New England Journal of Medicine"}],"dc:publisher":[{"@value":"Massachusetts Medical Society"}],"prism:publicationDate":"2012-02-02","prism:volume":"366","prism:number":"5","prism:startingPage":"399","prism:endingPage":"408"},"reviewed":"false","url":[{"@id":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1111961"}],"createdAt":"2011-12-11","modifiedAt":"2019-06-20","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004231200321280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pulmonary lymphocyte-rich classical Hodgkin lymphoma with early response to ABVD therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232927326976","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236759312896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861704777868544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Histopathological Impact of Bleomycin on Lung Injury and Development of Mediastinal Fat-Associated Lymphoid Clusters in the Lymphoproliferative Mouse Model"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa1111961"},{"@type":"CROSSREF","@value":"10.1007/s00277-013-1935-6_references_DOI_Oofj0KxzianG7dW1PPjtSWOQLUB"},{"@type":"CROSSREF","@value":"10.1182/blood-2012-05-431429_references_DOI_Oofj0KxzianG7dW1PPjtSWOQLUB"},{"@type":"CROSSREF","@value":"10.1017/s1431927622000654_references_DOI_Oofj0KxzianG7dW1PPjtSWOQLUB"},{"@type":"CROSSREF","@value":"10.1016/s2352-3026(18)30051-6_references_DOI_Oofj0KxzianG7dW1PPjtSWOQLUB"}]}